Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer.

被引：0
|
作者：
Chawla, Akhil
Shi, Qian
Ko, Andrew H.
Beg, Shaalan
Varghese, Anna M.
Behrman, Stephen W.
Bloomston, Mark
Ahmed, Firas Salem
Frankel, Wendy L.
Dixon, Jesse G.
Carrero, Xiomara W.
Shergill, Ardaman
Crawley, Jamie
Akin, Oguz
Renouf, Daniel John
Zogopoulos, George
Hubbard, Joleen M.
Meyerhardt, Jeffrey A.
O'Reilly, Eileen Mary
Ferrone, Cristina R.
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc, Chicago, IL USA
[2] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[4] UT Southwestern Simmons Canc Ctr, Dallas, TX USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
[6] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[7] South Florida Surg Oncol, Ft Myers, FL USA
[8] Columbia Univ, Med Ctr, New York, NY USA
[9] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[10] Univ Chicago, Sect Hematol & Oncol, Dept Med, Med Ctr, Chicago, IL USA
[11] Univ Chicago, Chicago, IL USA
[12] Univ British Columbia, BC Canc Agcy, Vancouver, BC, Canada
[13] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[14] Mayo Clin, Dept Med Oncol, Rochester, MN USA
[15] Alliance Clin Trials Oncol, Chicago, IL USA
[16] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4204
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ABC trial (A011502): Randomized phase III double blinded placebo controlled trial of aspirin as adjuvant therapy for breast cancer.
    Chen, Wendy Y.
    Winer, Eric P.
    Barry, William Thomas
    Partridge, Ann H.
    Carey, Lisa A.
    Carvan, Margaret
    Matyka, Carol
    Visvanathan, Kala
    Symington, Banu
    Holmes, Michelle D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] President: A Randomized Phase III Trial of Preoperative Chemoradiation Versus Post Operative Chemoradiation for Locally Advanced Potential Resectable Gastric Cancer.
    Zeng, M.
    Verma, V.
    Luo, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E505 - E506
  • [33] Perioperative Gemcitabine plus Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
    Wei, Alice C.
    Ou, Fang-Shu
    Shi, Qian
    Carrero, Xiomara
    O'Reilly, Eileen M.
    Meyerhardt, Jeffrey
    Wolff, Robert A.
    Kindler, Hedy L.
    Evans, Douglas B.
    Deshpande, Vikram
    Misdraji, Joseph
    Tamm, Eric
    Sahani, Dushyant
    Moore, Malcolm
    Newman, Elliot
    Merchant, Nipun
    Berlin, Jordan
    Goff, Laura W.
    Pisters, Peter
    Posner, Mitchell C.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4489 - 4497
  • [34] Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)
    Snyder, Rebecca A.
    Zemla, Tyler J.
    Shi, Qian
    Segovia, Diana
    Ahmad, Syed A.
    O'Reilly, Eileen M.
    Herman, Joseph M.
    Katz, Matthew H. G.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 7033 - 7042
  • [35] Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.
    Vasile, Enrico
    De Lio, Nelide
    Cappelli, Carla
    Pollina, Luca
    Funel, Niccola
    Sainato, Aldo
    Ginocchi, Laura
    Lucchesi, Maurizio
    Caparello, Chiara
    Caponi, Sara
    Perrone, Vittorio
    Pasqualetti, Francesco
    Caniglia, Fabio
    Signori, Stefano
    Mazzeo, Salvatore
    Greco, Carlo
    Falcone, Alfredo
    Campani, Daniela
    Mosca, Franco
    Boggi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] TOPGEAR: A randomized phase II/III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTC
    Leong, T.
    Smithers, B. M.
    Michael, M.
    Gebski, V.
    Simes, J.
    Boussioutas, A.
    Miller, D.
    Zalcberg, J.
    O'Connell, R.
    Swallow, C.
    Darling, G.
    Wong, R.
    Schuhmacher, C.
    Lordick, F.
    Haustermans, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S399 - S400
  • [37] Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Quality of life results of the randomized phase II AIO-NEONAX trial
    Ettrich, Thomas J.
    Buchholz, Sina
    Uhl, Waldemar
    Kornmann, Marko
    Algul, Hana
    Friess, Helmut
    Konig, Alexander-Otto
    Ghadimi, Michael
    Gallmeier, Eike
    Bartsch, Detlef K.
    Lutz, Manfred P.
    Metzger, Ralf
    Wille, Kai
    Gerdes, Bertold
    Schimanski, Carl C.
    Graupe, Florian
    Kunzmann, Volker
    Klein, Ingo
    Geissler, Michael
    Staib, Ludger
    Waldschmidt, Dirk
    Bruns, Christiane
    Wittel, Uwe A.
    Fichtner-Feigl, Stefan
    Daum, Severin
    Berger, Andreas
    Kestler, Angelika
    Schuhbaur, Jasmin
    Schutz, Juliane
    Perkhofer, Lukas
    Reinacher-Schick, Anke
    Seufferlein, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 77 - 78
  • [38] Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus A Phase III Randomized Trial
    Zhao, Yang
    Dai, ZhiJun
    Min, WeiLi
    Sui, Xin
    Kang, HuaFeng
    Zhang, YunFeng
    Ren, Hong
    Wang, XiJing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1349 - 1356
  • [39] Phase I Trial Evaluating the Safety of Preoperative Gemcitabine/nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer
    Takahashi, Hidenori
    Akita, Hirofumi
    Ioka, Tatsuya
    Wada, Hiroshi
    Tomokoni, Akira
    Asukai, Kei
    Ohue, Masayuki
    Yano, Masahiko
    Ishikawa, Osamu
    PANCREAS, 2018, 47 (09) : 1135 - 1141
  • [40] ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer.
    Chen, Wendy Y.
    Winer, Eric P.
    Ballman, Karla V.
    Partridge, Ann H.
    Carey, Lisa A.
    Carvan, Margaret
    Matyka, Carol
    Visvanathan, Kala
    Symington, Banu
    Holmes, Michelle D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345